The Bacteriuria In Renal Transplantation (BIRT) study: A prospective, randomized, parallel-group, multicenter, open-label, superiority trial comparing antibiotics versus no treatment in the prevention of symptomatic urinary tract infection in kidney transplant recipients with asymptomatic bacteriuria (protocol).
Julien Coussement(Institut Pasteur de la Guadeloupe), Daniel Abramowicz(Antwerp University Hospital), Herman Goossens(Kaneka (United States)), Judith Racapé, Sandrine Roisin, Steven Van Laecke(Ghent University Hospital), Magali Giral(Centre Hospitalier Universitaire de Nantes), Lidia Ghisdal, Karl Martin Wissing, Nilüfer Broeders, Laurent Weekers, Jean‐Louis Bosmans, Marc Hazzan, M. Kianda, Philippe Madhoun, Frédérique Jacobs(Université Libre de Bruxelles), Patrick Peeters
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)
October 1, 2014
Cited by 0
Related Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
|Proceedings of the National Academy of Sciences|2018|3.2k
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
|Journal of Clinical Investigation|2010|516
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411
Deep Dermatophytosis and Inherited CARD9 Deficiency
|New England Journal of Medicine|2013|403